Narayana Health

Germany's Siemens Healthineers on Friday announced strategic partnerships with HealthCare Global Enterprises, Narayana Health and the Indian Institute of Science as part of its strategy to make India an innovation centre for its global operations. The medical technology company said the partnerships will focus on fighting the most threatening diseases, enabling efficient operations and expanding access to patient care. In a virtual press conference, Siemens Healthineers Chief Technology Officer Peter Schardt said the partnership with HealthCare Global Enterprises Ltd (HCG) will focus on advancing cancer care with patient-centric solutions for the entire clinical pathway. It will also look to enhance research on diagnostic imaging technologies, artificial intelligence and precision therapy based on intelligent and image-guided treatment. With Narayana Health (NH), Schardt said the focus will be on improving cardiovascular care and the usage of interdisciplinary solutions to optimise

These connected sensors are similar to the patches which are used for ECGs and are placed on the patient's body to capture their vitals

In a Q&A, the executive vice-chairman of the hospital chain dwells on lessons from the pandemic, says hospital industry has always been dollar-exposed and thus had pressure on margins

TMS Ep206: India Inc succession strategy, Viren Shetty, markets, swimming

Is keeping it in the family a good for India Inc? How is Viren Shetty taking Narayana Health close to US? What will direct the markets in H2CY22? What is the 'open' category in swimming? Answers here

How is Viren Shetty taking Narayana Health biz close to US shores?

In a chat with Business Standard's Sohini Das, executive vice-chairman of Narayana Health, Viren Shetty tells about expansion plans within and outside India, and lessons learnt during the pandemic

Ganguly had twice been admitted to the hospital last year after complaining of chest discomfort

The company said Indian operations staged a decent recovery in the quarter gone by, after the significant impact was observed in Q1FY22.

Domestic firms are also sourcing ventilator parts from within the country to manufacture ventilators at a much lower cost

Currently this product has been launched for detection of cancers of the liver and colon. For leukemia, or blood cancer, further research is being conducted